80 related articles for article (PubMed ID: 20203160)
1. Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.
Ducloux D; Courivaud C; Bamoulid J; Vivet B; Chabroux A; Deschamps M; Rebibou JM; Ferrand C; Chalopin JM; Tiberghien P; Saas P
J Am Soc Nephrol; 2010 May; 21(5):868-75. PubMed ID: 20203160
[TBL] [Abstract][Full Text] [Related]
2. Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice.
Iovino L; Cooper K; deRoos P; Kinsella S; Evandy C; Ugrai T; Mazziotta F; Ensbey KS; Granadier D; Hopwo K; Smith C; Gagnon A; Galimberti S; Petrini M; Hill GR; Dudakov JA
Blood; 2022 Jun; 139(25):3655-3666. PubMed ID: 35357432
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of lymphocytopenia].
Berezné A; Bono W; Guillevin L; Mouthon L
Presse Med; 2006 May; 35(5 Pt 2):895-902. PubMed ID: 16710163
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.
Betjes MG; Weimar W; Litjens NH
J Transplant; 2013; 2013():841430. PubMed ID: 24288592
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.
Hewavisenti RV; Arena J; Ahlenstiel CL; Sasson SC
Front Immunol; 2023; 14():1112513. PubMed ID: 36960048
[TBL] [Abstract][Full Text] [Related]
6. Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients.
Pérez-Flores I; Juarez I; Aiffil Meneses AS; Lopez-Gomez A; Romero NC; Rodriguez-Cubillo B; Moreno de la Higuera MA; Peix-Jiménez B; Gonzalez-Garcia R; Baos-Muñoz E; Vilela AA; Gómez Del Moral M; Martínez-Naves E; Sanchez-Fructuoso AI
Front Immunol; 2023; 14():1111569. PubMed ID: 36817489
[TBL] [Abstract][Full Text] [Related]
7. Anti-thymocyte globulin-mediated immunosenescent alterations of T cells in kidney transplant patients.
Lee GH; Lee JY; Jang J; Kang YJ; Choi SA; Kim HC; Park S; Kim MS; Lee WW
Clin Transl Immunology; 2022; 11(11):e1431. PubMed ID: 36439636
[TBL] [Abstract][Full Text] [Related]
8. Durability of Antibody Response after Primary Pneumococcal Double-Dose Prime-Boost Vaccination in Adult Kidney Transplant Recipients and Candidates: 18-Month Follow-Up in a Non-Blinded, Randomised Clinical Trial.
Larsen L; Bistrup C; Sørensen SS; Boesby L; Jørgensen CS; Nielsen C; Johansen IS
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891255
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Evaluation of Cytopenias in the Renal Transplant Population.
Johnson AC; Karadkhele G; Magua W; Vasanth P; Larsen CP
Transplant Direct; 2022 Jun; 8(6):e1339. PubMed ID: 35651583
[TBL] [Abstract][Full Text] [Related]
10. Induction Therapy and Therapeutic Antibodies.
Nikolova A; Patel JK
Handb Exp Pharmacol; 2022; 272():85-116. PubMed ID: 35474024
[TBL] [Abstract][Full Text] [Related]
11. Effect of Kidney Transplantation on Accelerated Immunosenescence and Vascular Changes Induced by Chronic Kidney Disease.
Ceprian N; Valera G; Caro J; Yuste C; Serroukh N; González de Pablos I; Oliva C; Figuer A; Praga M; Alique M; Ramirez R; Morales E; Carracedo J
Front Med (Lausanne); 2021; 8():705159. PubMed ID: 34646838
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients.
Ducloux D; Colladant M; Chabannes M; Bamoulid J; Courivaud C
Clin Kidney J; 2021 Oct; 14(10):2270-2272. PubMed ID: 34603706
[No Abstract] [Full Text] [Related]
13. Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing.
Rios-Navarro C; Dios E; Forteza MJ; Bodi V
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2240-H2254. PubMed ID: 33844596
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation.
Courivaud C; Bamoulid J; Crepin T; Gaiffe E; Laheurte C; Saas P; Ducloux D
Front Immunol; 2020; 11():1653. PubMed ID: 32903778
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic CD4 Lymphocytopenia: Current Insights.
Vijayakumar S; Viswanathan S; Aghoram R
Immunotargets Ther; 2020; 9():79-93. PubMed ID: 32548074
[TBL] [Abstract][Full Text] [Related]
16. Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
Song T; Yin S; Li X; Jiang Y; Lin T
Front Immunol; 2020; 11():457. PubMed ID: 32318057
[No Abstract] [Full Text] [Related]
17. Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses.
Betjes MG
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260178
[TBL] [Abstract][Full Text] [Related]
18. A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation.
Betjes MGH; Langerak AW; Klepper M; Litjens NHR
Immun Ageing; 2020; 17():4. PubMed ID: 32082402
[TBL] [Abstract][Full Text] [Related]
19. T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO- versus HLA-incompatible kidney transplant recipients.
Del Bello A; Kamar N; Treiner E
Clin Exp Immunol; 2020 Apr; 200(1):89-104. PubMed ID: 31869432
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients.
Camargo JF; Pallikkuth S; Moroz I; Natori Y; Alcaide ML; Rodriguez A; Guerra G; Burke GW; Pahwa S
Kidney Int Rep; 2019 Dec; 4(12):1705-1716. PubMed ID: 31844807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
